Do selective topical β antagonists for glaucoma have respiratory side effects?

Background/aims: Topical β antagonists are prescribed for glaucoma in approximately 500 000 people in the United Kingdom. The authors have previously shown that topical β antagonists are associated with an excess incidence of airways obstruction. They examined whether selective topical β antagonists...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kirwan, J F, Nightingale, J A, Bunce, C, Wormald, R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Copyright 2004 British Journal of Ophthalmology 2004
Gaiak:
Clinical Science - Scientific Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1771974/
https://ncbi.nlm.nih.gov/pubmed/14736772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2003.017715
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak